Sonnet BioTherapeutics (SONN) Revenue & Revenue Breakdown
Sonnet BioTherapeutics Revenue Highlights
Latest Revenue (Y)
$147.81K
Main Segment (Y)
Better Burgers Fast Casual
Main Geography (Y)
United States
Sonnet BioTherapeutics Revenue by Period
Sonnet BioTherapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $147.81K | -57.76% |
| 2022-09-30 | $349.94K | -27.64% |
| 2021-09-30 | $483.63K | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2019-09-30 | $40.61M | -1.98% |
| 2017-12-31 | $41.43M | -0.65% |
| 2016-12-31 | $41.70M | -1.64% |
| 2015-12-31 | $42.40M | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $17.50M | - |
Sonnet BioTherapeutics generated $147.81K in revenue during NA 2023, up -57.76% compared to the previous quarter, and up 0.36% compared to the same period a year ago.
Sonnet BioTherapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $18.63K | -50.00% |
| 2023-09-30 | $37.26K | 1.10% |
| 2023-06-30 | $36.85K | 1.11% |
| 2023-03-31 | $36.45K | -2.17% |
| 2022-12-31 | $37.26K | -40.63% |
| 2022-09-30 | $62.75K | 1.10% |
| 2022-06-30 | $62.07K | -34.88% |
| 2022-03-31 | $95.32K | -26.56% |
| 2021-12-31 | $129.80K | -73.16% |
| 2021-09-30 | $483.63K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2020-09-30 | $-5.68M | 100.00% |
| 2020-06-30 | - | -100.00% |
| 2020-03-31 | $5.68M | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2019-09-30 | $9.65M | -9.87% |
| 2019-06-30 | $10.71M | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2018-09-30 | $10.10M | 1.03% |
| 2018-03-31 | $10.00M | -6.80% |
| 2017-09-30 | $10.73M | 8.78% |
| 2017-03-31 | $9.86M | -10.17% |
| 2016-09-30 | $10.98M | 2.09% |
| 2016-06-30 | $10.75M | 4.68% |
| 2015-09-30 | $10.27M | -4.83% |
| 2015-06-30 | $10.79M | 12.12% |
| 2014-09-30 | $9.63M | 39.12% |
| 2014-06-30 | $6.92M | 330.81% |
| 2013-09-30 | $1.61M | -3.65% |
| 2013-03-31 | $1.67M | -5.68% |
| 2012-09-30 | $1.77M | - |
Sonnet BioTherapeutics generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Sonnet BioTherapeutics Revenue Breakdown
Sonnet BioTherapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 18 |
|---|---|
| Corporate and Other | $100.00K |
| Hooters Full Service | $13.84M |
| Just Fresh Fast Casual | $4.05M |
| Better Burgers Fast Casual | $22.62M |
Sonnet BioTherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 18: Better Burgers Fast Casual (55.69%), Hooters Full Service (34.08%), Just Fresh Fast Casual (9.98%), and Corporate and Other (0.25%).
Quarterly Revenue by Product
| Product/Service | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|
| Hooters Full Service | $2.89M | $3.34M | $3.35M | $3.41M | $3.39M | $3.51M |
| Just Fresh Fast Casual | $943.52K | $1.01M | $967.88K | $926.05K | $989.10K | $1.06M |
| Corporate and Other | $50.00K | $25.00K | $25.00K | $25.00K | $25.00K | $25.00K |
| Better Burgers Fast Casual | $5.82M | $6.33M | $5.86M | $5.76M | $5.69M | $5.80M |
Sonnet BioTherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 19: Better Burgers Fast Casual (60.02%), Hooters Full Service (29.74%), Just Fresh Fast Casual (9.72%), and Corporate and Other (0.52%).
Sonnet BioTherapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 18 |
|---|---|
| South Africa | $5.83M |
| United States | $31.93M |
| Europe | $2.86M |
Sonnet BioTherapeutics's latest annual revenue breakdown by geography, as of Dec 18: United States (78.62%), South Africa (14.34%), and Europe (7.04%).
Quarterly Revenue by Country
| Country | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|
| South Africa | $1.38M | $1.35M | $1.39M | $1.50M | $1.35M | $1.47M |
| Just Fresh Fast Casual | $943.52K | - | - | - | - | - |
| Hooters Full Service | $2.89M | - | - | - | - | - |
| Corporate and Other | - | - | - | - | - | - |
| Better Burgers Fast Casual | $5.82M | - | - | - | - | - |
| Europe | $634.41K | $709.73K | $652.73K | $670.11K | $707.51K | $768.00K |
| United States | $7.64M | $8.65M | $8.15M | $7.95M | $8.04M | $8.16M |
Sonnet BioTherapeutics's latest quarterly revenue breakdown by geography, as of Sep 19: United States (39.55%), Better Burgers Fast Casual (30.16%), Hooters Full Service (14.95%), South Africa (7.17%), Just Fresh Fast Casual (4.89%), and Europe (3.29%).
SONN Revenue FAQ
What is Sonnet BioTherapeutics’s yearly revenue?
Sonnet BioTherapeutics's yearly revenue for 2023 was $147.8K, representing a decrease of -57.76% compared to 2022. The company's yearly revenue for 2022 was $349.94K, representing a decrease of -27.64% compared to 2021. SONN's yearly revenue for 2021 was $483.63K, representing an increase of 100.00% compared to 2020.
What is Sonnet BioTherapeutics’s quarterly revenue?
Sonnet BioTherapeutics's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $18.63K, a -50.00% decrease from the previous quarter (Q4 2023), and a -50.00% decrease year-over-year (Q1 2023). SONN's quarterly revenue for Q4 2023 was $37.26K, a 1.10% increase from the previous quarter (Q3 2023), and a -40.63% decrease year-over-year (Q4 2022).
What is Sonnet BioTherapeutics’s revenue growth rate?
Sonnet BioTherapeutics's revenue growth rate for the last 3 years (2021-2023) was -69.44%, and for the last 5 years (2019-2023) was -99.64%.
What are Sonnet BioTherapeutics’s revenue streams?
Sonnet BioTherapeutics's revenue streams in c 18 are Corporate and Other, Hooters Full Service, Just Fresh Fast Casual, and Better Burgers Fast Casual. Corporate and Other generated $100K in revenue, accounting 0.25% of the company's total revenue Hooters Full Service generated $13.84M in revenue, accounting 34.08% of the company's total revenue Just Fresh Fast Casual generated $4.05M in revenue, accounting 9.98% of the company's total revenue Better Burgers Fast Casual generated $22.62M in revenue, accounting 55.69% of the company's total revenue
What is Sonnet BioTherapeutics’s main source of revenue?
For the fiscal year ending Dec 18, the largest source of revenue of Sonnet BioTherapeutics was Better Burgers Fast Casual. This segment made a revenue of $22.62M, representing 55.69% of the company's total revenue.